These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9551671)

  • 1. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
    Lau GK; Liang R; Wu PC; Lee CK; Lim WL; Au WY
    J Hepatol; 1998 Mar; 28(3):359-68. PubMed ID: 9551671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer.
    Lau GK; Yuen ST; Au WY; Wu PC; Liang R
    J Gastroenterol Hepatol; 1999 Mar; 14(3):262-8. PubMed ID: 10197497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
    Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR
    Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
    Kruger M; Böker KH; Zeidler H; Manns MP
    J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.
    Wu Y; Huang H; Luo Y
    Front Immunol; 2020; 11():610500. PubMed ID: 33613534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation.
    Henkes M; Martin S; Einsele H; Aulitzky WE
    Ann Hematol; 2002 Jun; 81(6):343-6. PubMed ID: 12107567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.
    Seto WK; Chan TS; Hwang YY; Wong DK; Fung J; Liu KS; Gill H; Lam YF; Lau EHY; Cheung KS; Lie AKW; Lai CL; Kwong YL; Yuen MF
    Hepatology; 2017 May; 65(5):1451-1461. PubMed ID: 28027590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
    Yağci M; Acar K; Sucak GT; Aki Z; Bozdayi G; Haznedar R
    Leuk Lymphoma; 2006 Aug; 47(8):1608-12. PubMed ID: 16966273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results.
    Berenguer M; Prieto M; Rayón M; Bustamante M; Carrasco D; Moya A; Pastor MA; Gobernado M; Mir J; Berenguer J
    Am J Gastroenterol; 2001 Feb; 96(2):526-33. PubMed ID: 11232701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
    Manns MP; Neuhaus P; Atkinson GF; Griffin KE; Barnass S; Vollmar J; Yeang Y; Young CL;
    Transpl Infect Dis; 2001 Mar; 3(1):16-23. PubMed ID: 11429035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.
    Lau GK; Nanji A; Hou J; Fong DY; Au WS; Yuen ST; Lin M; Kung HF; Lam SK
    J Viral Hepat; 2002 Jul; 9(4):280-7. PubMed ID: 12081605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
    Lim SG; Wai CT; Rajnakova A; Kajiji T; Guan R
    Gut; 2002 Oct; 51(4):597-9. PubMed ID: 12235087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.
    Koc Y; Miller KB; Schenkein DP; Griffith J; Akhtar M; DesJardin J; Snydman DR
    Biol Blood Marrow Transplant; 2000; 6(1):44-9. PubMed ID: 10707998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.
    Wu Y; Chen Y; Zhu P; Ye B; Lu Y; Shi J; Tan Y; Zhao Y; Yu J; Lai X; Lan J; Si T; Ni L; Huang H; Luo Y
    Ann Hematol; 2022 Mar; 101(3):631-641. PubMed ID: 34981143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.
    Wedemeyer H; Böker KH; Pethig K; Petzold DR; Flemming P; Tillmann HL; Vollmar J; Bastürk M; Goldmann E; Griffin KE; Haverich A; Manns MP
    Transplantation; 1999 Nov; 68(10):1503-11. PubMed ID: 10589947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
    Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
    J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.